Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/7EEvIICqQHM/267313.php
Friday, 11 October 2013
New hepatitis C drug shows promising results in phase II trials
Promising results from a phase II trial published in the journal Gastroenterology suggest adding the new drug danoprevir to the current standard care (peginterferon and ribavirin) for patients with hepatitis C leads to high rates of remission. The results raise hopes that Roche's new drug can improve the quality of life for patients with hepatitis C. Lead author Dr...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment